Answers are grounded in this paper and cite their sources.
Key Points Fifteen percent of NCI high-risk, Ph-negative, B-ALL patients harbored a kinase-activating fusion, and often associated with IKZF1 deletion. IKZF1 deletion represents an independent prognostic factor of poor outcomes, regardless of fusion-positivity.
No takes yet. Share an insight, caveat, or question.
Tran et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: